NO20001894L - Use of TNF antagonists as drugs for the treatment of septic diseases - Google Patents

Use of TNF antagonists as drugs for the treatment of septic diseases

Info

Publication number: NO20001894L
Authority: NO; Norway
Prior art keywords: drugs; treatment; tnf antagonists; septic diseases; septic
Prior art date: 1997-10-23

Application number

NO20001894A

Other languages

Norwegian (no)

Other versions

NO20001894D0 (en

Inventor

Hartmut Kupper

Martin Kaul

Juergen Eiselstein

Lothar Daum

Joachim Kempeni

Original Assignee

Knoll Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-23

Filing date

2000-04-12

Publication date

2000-04-12

2000-04-12 Application filed by Knoll Ag filed Critical Knoll Ag

2000-04-12 Publication of NO20001894L publication Critical patent/NO20001894L/en

2000-04-12 Publication of NO20001894D0 publication Critical patent/NO20001894D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Diabetes (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20001894A 1997-10-23 2000-04-12 Use of TNF antagonists as drugs for the treatment of septic diseases NO20001894D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19746868A DE19746868A1 (en)	1997-10-23	1997-10-23	Use of tumour necrosis factor antagonists
PCT/EP1998/006545 WO1999021582A2 (en)	1997-10-23	1998-10-15	Application of tnf antagonists as medicaments for treating septic diseases

Publications (2)

Publication Number	Publication Date
NO20001894L true NO20001894L (en)	2000-04-12
NO20001894D0 NO20001894D0 (en)	2000-04-12

Family

ID=7846420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001894A NO20001894D0 (en)	1997-10-23	2000-04-12	Use of TNF antagonists as drugs for the treatment of septic diseases

Country Status (13)

Country	Link
EP (1)	EP1024831A2 (en)
JP (1)	JP2001521009A (en)
KR (1)	KR20010024549A (en)
CN (1)	CN1163272C (en)
AU (1)	AU756167B2 (en)
BR (1)	BR9813114A (en)
CA (1)	CA2306790A1 (en)
DE (1)	DE19746868A1 (en)
HU (1)	HUP0100105A3 (en)
IL (1)	IL135083A0 (en)
NO (1)	NO20001894D0 (en)
WO (1)	WO1999021582A2 (en)
ZA (1)	ZA989615B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2181297C2 (en)	2000-06-20	2002-04-20	Эпштейн Олег Ильич	Method of treatment of pathological syndrome and medicinal agent
UA76640C2 (en) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Method for correcting pathological immune responses and homeopathic medicinal agent
UA76639C2 (en)	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Homeopathic medication and method for treating erectile dysfunctions
RU2309732C1 (en)	2006-03-13	2007-11-10	Олег Ильич Эпштейн	Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
DE112011102355T5 (en)	2010-07-15	2013-04-25	Oleg Iliich Epshtein	A combination pharmaceutical composition and method for the treatment of functional diseases or conditions of the gastrointestinal tract
BR112013000840A2 (en)	2010-07-15	2016-06-07	Oleg Lliich Epshtein	method for enhancing the effect of potentiated activated form of antibody to biological endogenous molecule, pharmaceutical composition and use of combination of endogenous biological molecule with potentiated activated form of antibody to endothelial synthase.
EP2415461B1 (en) *	2010-07-24	2012-10-31	Roche Diagnostics GmbH	Stabilization of interleukin 6 in serum based solutions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2638652B2 (en) *	1988-07-18	1997-08-06	カイロン・コーポレーション	Monoclonal antibody reacting with cachectin
GB9109645D0 (en) *	1991-05-03	1991-06-26	Celltech Ltd	Recombinant antibodies
NZ278607A (en) *	1994-02-07	1999-05-28	Knoll Ag	Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above

1997
- 1997-10-23 DE DE19746868A patent/DE19746868A1/en not_active Withdrawn
1998
- 1998-10-15 AU AU12284/99A patent/AU756167B2/en not_active Withdrawn - After Issue
- 1998-10-15 KR KR1020007004361A patent/KR20010024549A/en not_active Application Discontinuation
- 1998-10-15 BR BR9813114-1A patent/BR9813114A/en not_active IP Right Cessation
- 1998-10-15 JP JP2000517740A patent/JP2001521009A/en active Pending
- 1998-10-15 HU HU0100105A patent/HUP0100105A3/en unknown
- 1998-10-15 IL IL13508398A patent/IL135083A0/en unknown
- 1998-10-15 CN CNB988105144A patent/CN1163272C/en not_active Expired - Fee Related
- 1998-10-15 EP EP98955459A patent/EP1024831A2/en not_active Withdrawn
- 1998-10-15 WO PCT/EP1998/006545 patent/WO1999021582A2/en not_active Application Discontinuation
- 1998-10-15 CA CA002306790A patent/CA2306790A1/en not_active Abandoned
- 1998-10-22 ZA ZA9809615A patent/ZA989615B/en unknown
2000
- 2000-04-12 NO NO20001894A patent/NO20001894D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0100105A3 (en)	2003-08-28
WO1999021582A2 (en)	1999-05-06
IL135083A0 (en)	2001-05-20
AU1228499A (en)	1999-05-17
BR9813114A (en)	2000-08-15
EP1024831A2 (en)	2000-08-09
ZA989615B (en)	2000-04-20
CA2306790A1 (en)	1999-05-06
CN1163272C (en)	2004-08-25
KR20010024549A (en)	2001-03-26
HUP0100105A2 (en)	2001-05-28
AU756167B2 (en)	2003-01-09
JP2001521009A (en)	2001-11-06
DE19746868A1 (en)	1999-04-29
CN1277556A (en)	2000-12-20
NO20001894D0 (en)	2000-04-12
WO1999021582A3 (en)	1999-07-15

Publication	Publication Date	Title
IS5113A (en)	1999-07-12	Use of CB1 antagonists for the treatment of craving disorders
NO20006630D0 (en)	2000-12-22	Pharmaceutical composition for the treatment of diabetes
NO995221D0 (en)	1999-10-26	Sulfonamides for the treatment of endothelin-mediated diseases
NO20014379L (en)	2001-11-07	Use of Xenon for the Treatment of Neurointoxics
ATE447947T1 (en)	2009-11-15	PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
DK0730864T3 (en)	2004-03-01	Medication for the treatment of inflammatory heart disease
EE200300214A (en)	2003-08-15	Sulfonamides for the treatment of endothelin-mediated diseases
DE69807466D1 (en)	2002-10-02	TRIPTOLID DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE69838785D1 (en)	2008-01-10	PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
FI971527L (en)	1997-04-11	Use of indole derivatives for the treatment of various diseases
NO20012106D0 (en)	2001-04-27	Drug for the treatment of bone pathobolism
NO20001894L (en)	2000-04-12	Use of TNF antagonists as drugs for the treatment of septic diseases
DE69822297D1 (en)	2004-04-15	TRIPTOLID DERIVATIVES SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
NO20020784D0 (en)	2002-02-18	Medication for the treatment of fractures
NO991734D0 (en)	1999-04-13	Pyrazolinones for the treatment of potency disorders
NO991164D0 (en)	1999-03-10	Pharmaceutical surface preparation for the treatment of viral diseases
NO20012612L (en)	2001-07-17	Isonipecotamides for the treatment of integrin-mediated diseases
NO20003799L (en)	2001-01-29	Incorporation of cholesterol-lowering agents into confectionary dosage forms
NO982562D0 (en)	1998-06-04	Composition for the treatment of pain
NO20002481D0 (en)	2000-05-12	Combination therapy for the treatment of AIDS
DE60043648D1 (en)	2010-02-25	MEDICAMENTS FOR THE TREATMENT OF PERIODONTAL DISEASES
EP1244467A4 (en)	2005-01-05	PHOSPHOLGLYERATE KINASE FOR THE TREATMENT OF DISEASES
ID24439A (en)	2000-07-20	USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
DK0900078T3 (en)	2000-06-19	Use of benzonaphthalene derivatives for the manufacture of drugs for the treatment of diseases of the nervous system
NO995940D0 (en)	1999-12-03	Use of leptin antagonists for the treatment of diabetes

Legal Events

Date	Code	Title	Description
2006-05-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application